The therapeutic effects of MSc1 nanocomplex, synthesized by nanochelating technology, on experimental autoimmune encephalomyelitic C57/BL6 mice

References

• GrigoriadisNInterferon beta treatment in relapsing-remitting multiple sclerosis. A reviewClin Neurol Neurosurg2002104325125812127664
   PubMed Web of Science ®Google Scholar
• McDonaghMDrug Class Review: Disease-Modifying Drugs for Multiple Sclerosis: Single Drug Addendum: FingolimodPortlandOregon Health & Science University2011
   Google Scholar
• HartungHPNew cases of progressive multifocal leukoencephalopathy after treatment with natalizumabLancet Neurol200981283119081511
   PubMed Web of Science ®Google Scholar
• MullenJTVartanianTKAtkinsMBMelanoma complicating treatment with natalizumab for multiple sclerosisN Engl J Med2008358664764818256405
   PubMed Web of Science ®Google Scholar
• LindseyJWHaden-PinneriKMemonNBBujaLMSudden unexpected death on fingolimodMult Scler201218101507150822300970
   PubMed Web of Science ®Google Scholar
• BernardCCKerlero de RosboNMultiple sclerosis: an autoimmune disease of multifactorial etiologyCurr Opin Immunol1992467607651281641
   PubMed Web of Science ®Google Scholar
• MurrayTJThe history of multiple sclerosis: the changing frame of the disease over the centuriesJ Neurol Sci2009277Suppl 1S3S819200863
   PubMedGoogle Scholar
• ZettlUKStuveOPatejdlRImmune-mediated CNS diseases: a review on nosological classification and clinical featuresAutoimmun Rev201211316717321619943
   PubMed Web of Science ®Google Scholar
• Muñoz-CullaMIrizarHOtaeguiDThe genetics of multiple sclerosis: review of current and emerging candidatesAppl Clin Genet20136637324019748
   PubMedGoogle Scholar
• GraberJJDhib-JalbutSProtective autoimmunity in the nervous systemPharmacol Ther2009121214715919000712
   PubMed Web of Science ®Google Scholar
• MartinoGFurlanRBrambillaECytokines and immunity in multiple sclerosis: the dual signal hypothesisJ Neuroimmunol200010913910969174
   PubMed Web of Science ®Google Scholar
• HametnerSWimmerIHaiderLPfeifenbringSBrückWLassmannHIron and neurodegeneration in the multiple sclerosis brainAnn Neurol201374684886123868451
   PubMed Web of Science ®Google Scholar
• SuKBourdetteDForteMMitochondrial dysfunction and neurodegeneration in multiple sclerosisFront Physiol2013416923898299
   PubMed Web of Science ®Google Scholar
• ZundorfGReiserGCalcium dysregulation and homeostasis of neural calcium in the molecular mechanisms of neurodegenerative diseases provide multiple targets for neuroprotectionAntioxid Redox Signal20111471275128820615073
   PubMed Web of Science ®Google Scholar
• CrichtonRRDexterDTWardRJBrain iron metabolism and its perturbation in neurological diseasesJ Neural Transm2011118330131420809066
   PubMed Web of Science ®Google Scholar
• TodorichBPasquiniJMGarciaCIPaezPMConnorJROligodendrocytes and myelination: the role of ironGlia200957546747818837051
   PubMed Web of Science ®Google Scholar
• ForgeJKPedchenkoTVLeVineSMIron deposits in the central nervous system of SJL mice with experimental allergic encephalomyelitisLife Sci19986325227122849870713
   PubMed Web of Science ®Google Scholar
• AdamsCWPerivascular iron deposition and other vascular damage in multiple sclerosisJ Neurol Neurosurg Psychiatry19885122602653346691
   PubMed Web of Science ®Google Scholar
• RussoCSmokerWRKubalWCortical and subcortical T2 shortening in multiple sclerosisAJNR Am J Neuroradiol19971811241269010530
   PubMed Web of Science ®Google Scholar
• HegdeMLBharathiPSuramAChallenges associated with metal chelation therapy in Alzheimer’s diseaseJ Alzheimers Dis200917345746819363258
   PubMed Web of Science ®Google Scholar
• WeinbergEDTherapeutic potential of iron chelators in diseases associated with iron mismanagementJ Pharm Pharmacol200658557558416640825
   PubMed Web of Science ®Google Scholar
• YoshidaMLahannJSmart nanomaterialsACS Nano2008261101110719206325
   PubMed Web of Science ®Google Scholar
• XiongYRenCZhangBAnalyzing the behavior of a porous nano-hydroxyapatite/polyamide 66 (n-HA/PA66) composite for healing of bone defectsInt J Nanomedicine2014948549424531621
   PubMed Web of Science ®Google Scholar
• SajadMZarganJChawlaRUmarSSadaqatMKhanHAHippocampal neurodegeneration in experimental autoimmune encephalomyelitis (EAE): potential role of inflammation activated myeloperoxidaseMol Cell Biochem20093281–218318819301098
   PubMed Web of Science ®Google Scholar
• MirshafieyAMohsenzadeganMAntioxidant therapy in multiple sclerosisImmunopharmacol Immunotoxicol2009311132918763202
   PubMed Web of Science ®Google Scholar
• WuFJXueYLiuXFThe protective effect of eicosapentaenoic acid-enriched phospholipids from sea cucumber Cucumaria frondosa on oxidative stress in PC12 cells and SAMP8 miceNeurochem Int20146491724231470
   PubMed Web of Science ®Google Scholar
• NazaranMHinventorChelate compounds United States patent US 8288587 B210162012
   Google Scholar
• NazaranMHinventorChelate compounds Patent EP2444096 A14252012
   Google Scholar
• SiCLShenTJiangYYAntioxidant properties and neuroprotective effects of isocampneoside II on hydrogen peroxide-induced oxidative injury in PC12 cellsFood Chem Toxicol20135914515223770344
   PubMed Web of Science ®Google Scholar
• YuanBZhaoLFuFA novel nanoparticle containing MOG peptide with BTLA induces T cell tolerance and prevents multiple sclerosisMol Immunol2014572939924084097
   PubMed Web of Science ®Google Scholar
• ZhuBTrikudanathanSZozulyaALImmune modulation by lacto-N-fucopentaose III in experimental autoimmune encephalomyelitisClin Immunol2012142335136122264636
   PubMed Web of Science ®Google Scholar
• MandelSAmitTBar-AmOYoudimMBIron dysregulation in Alzheimer’s disease: multimodal brain permeable iron chelating drugs possessing neuroprotective-neurorescue and amyloid precursor protein-processing regulatory activities as therapeutic agentsProg Neurobiol200782634836017659826
   PubMed Web of Science ®Google Scholar
• RennoWMAl-MaghrebiMAlshammariAGeorgeP(-)-Epigallocatechin-3-gallate (EGCG) attenuates peripheral nerve degeneration in rat sciatic nerve crush injuryNeurochem Int201362322123123313191
   PubMed Web of Science ®Google Scholar
• SilvaKCRosalesMAHamassakiDEGreen tea is neuroprotective in diabetic retinopathyInvest Ophthalmol Vis Sci20135421325133623299475
   PubMed Web of Science ®Google Scholar
• AktasOProzorovskiTSmorodchenkoAGreen tea epigallocatechin-3-gallate mediates T cellular NF-kappa B inhibition and exerts neuroprotection in autoimmune encephalomyelitisJ Immunol200417395794580015494532
   PubMed Web of Science ®Google Scholar
• ProniukSLiedererBMBlanchardJPreformulation study of epigallocatechin gallate a promising antioxidant for topical skin cancer preventionJ Pharm Sci200291111111611782902
   PubMed Web of Science ®Google Scholar
• HirunSRoachPDA study of stability of (-)-epigallocatechin gallate (EGCG) from green tea in a frozen productInt Food Res J201118412611264
   Google Scholar
• HagermanAEDeanRTDaviesMJRadical chemistry of epigallocatechin gallate and its relevance to protein damageArch Biochem Biophys2003414111512012745262
   PubMed Web of Science ®Google Scholar
• LambDJLeakeDSIron released from transferrin at acidic pH can catalyse the oxidation of low density lipoproteinFEBS Lett1994352115187925932
   PubMed Web of Science ®Google Scholar
• SteenKHSteenAEReehPWA dominant role of acid pH in inflammatory excitation and sensitization of nociceptors in rat skin in vitroJ Neurosci1995155 Pt 2398239897751959
   PubMed Web of Science ®Google Scholar
• YamajiYNakazatoYOshimaNHayashiMSarutaTOxidative stress induced by iron released from transferrin in low pH peritoneal dialysis solutionNephrol Dial Transplant200419102592259715292463
   PubMed Web of Science ®Google Scholar
• YuHCFengSFChaoPLLinAMAnti-inflammatory effects of pioglitazone on iron-induced oxidative injury in the nigrostriatal dopaminergic systemNeuropathol Appl Neurobiol201036761262220626630
   PubMed Web of Science ®Google Scholar
• ZimeckiMKociebaMChodaczekGHouszkaMKruzelMLLactoferrin ameliorates symptoms of experimental encephalomyelitis in Lewis ratsJ Neuroimmunol20071821–216016617113653
   PubMed Web of Science ®Google Scholar
• MazurierJSpikGComparative study of the iron-binding properties of human transferrins. I. Complete and sequential iron saturation and desaturation of the lactotransferrinBiochim Biophys Acta198062923994086770907
   PubMed Web of Science ®Google Scholar
• ShojiHOguchiSShinoharaKShimizuTYamashiroYEffects of iron-unsaturated human lactoferrin on hydrogen peroxide-induced oxidative damage in intestinal epithelial cellsPediatr Res2007611899217211147
   PubMed Web of Science ®Google Scholar
• TalerMGil-AdIKorobIWeizmanAThe immunomodulatory effect of the antidepressant sertraline in an experimental autoimmune encephalomyelitis mouse model of multiple sclerosisNeuroimmunomodulation201118211712221088435
   PubMed Web of Science ®Google Scholar
• QuinnKGalbraithSESheahanBJAtkinsGJEffect of intranasal administration of Semliki Forest virus recombinant particles expressing interferon-β on the progression of experimental autoimmune encephalomyelitisMol Med Rep20081333534221479414
   PubMed Web of Science ®Google Scholar
• SegerJZorzella-PezaventoSFPelizonACMartinsDRDominguesASartoriADecreased production of TNF-alpha by lymph node cells indicates experimental autoimmune encephalomyelitis remission in Lewis ratsMem Inst Oswaldo Cruz2010105326326820512238
   PubMed Web of Science ®Google Scholar
• WuFCaoWYangYLiuAExtensive infiltration of neutrophils in the acute phase of experimental autoimmune encephalomyelitis in C57BL/6 miceHistochem Cell Biol2010133331332220063008
   PubMed Web of Science ®Google Scholar
• CarlsonTKroenkeMRaoPLaneTESegalBThe Th17-ELR+ CXC chemokine pathway is essential for the development of central nervous system autoimmune diseaseJ Exp Med2008205481182318347102
   PubMed Web of Science ®Google Scholar